Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 98801-98850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04580225
Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE)
NARecruiting
120 participants
Started: Jan 7, 2021 · Completed: Sep 30, 2025
8 conditions3 sponsors6 locations
NCT06263062
Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study
NARecruiting
60 participants
Started: Jan 7, 2021 · Completed: Jun 15, 2024
2 conditions1 sponsor1 location
NCT04672681
Rehabilitation Including Structured Active Play for Preschoolers With Cancer.
NAActive, not recruiting
84 participants
Started: Jan 7, 2021 · Completed: Dec 30, 2026
1 condition4 sponsors1 location
NCT04865250
Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC
PHASE2Recruiting
20 participants
Started: Jan 7, 2021 · Completed: Dec 30, 2026
3 conditions2 sponsors1 location
NCT04342039
Epigenetic Health Benefits of Budesonide
PHASE4Active, not recruiting
20 participants
Started: Jan 7, 2021 · Completed: Dec 31, 2027
2 conditions3 sponsors1 location
NCT04635111
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
N/ARecruiting
30 participants
Started: Jan 7, 2021 · Completed: Jun 1, 2036
2 conditions1 sponsor8 locations
NCT04402788
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
PHASE2/PHASE3Recruiting
138 participants
Started: Jan 7, 2021 · Completed: Apr 30, 2027
1 condition2 sponsors412 locations
NCT04577599
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
NARecruiting
1,160 participants
Started: Jan 7, 2021 · Completed: Oct 31, 2028
2 conditions2 sponsors1 location
NCT04438525
Is the BAT Inhibition Able to Replace Sting Challenges? (BATIRS)
NARecruiting
219 participants
Started: Jan 7, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04322383
Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
PHASE2Recruiting
40 participants
Started: Jan 7, 2021 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT05793034
Predictive Factors for Survival in Aggressive Meningiomas
NARecruiting
250 participants
Started: Jan 7, 2021 · Completed: Jan 7, 2027
3 conditions1 sponsor1 location
NCT04534205
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
PHASE2/PHASE3Recruiting
350 participants
Started: Jan 7, 2021 · Completed: Apr 30, 2029
3 conditions1 sponsor188 locations
NCT04118387
Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment
PHASE4Recruiting
200 participants
Started: Jan 7, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04581447
Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care
PHASE3Recruiting
126 participants
Started: Jan 7, 2021 · Completed: Nov 30, 2026
3 conditions2 sponsors16 locations
NCT04304846
AttachMent Preterm in the Loire Infant Follow-up Team
N/ARecruiting
90 participants
Started: Jan 7, 2021 · Completed: Jan 6, 2027
1 condition1 sponsor2 locations
NCT04685473
Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors
PHASE1Active, not recruiting
24 participants
Started: Jan 7, 2021 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT04844359
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
N/AActive, not recruiting
137 participants
Started: Jan 6, 2021 · Completed: Jul 31, 2025
1 condition7 sponsors7 locations
NCT04511013
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
PHASE2Recruiting
112 participants
Started: Jan 6, 2021 · Completed: Jun 30, 2027
7 conditions2 sponsors331 locations
NCT04167917
NTX-301 in MDS/AML
PHASE1Active, not recruiting
22 participants
Started: Jan 6, 2021 · Completed: Mar 31, 2026
3 conditions1 sponsor2 locations
NCT04826770
Adaptive Immune Response to COVID-19 Vaccination
N/AActive, not recruiting
70 participants
Started: Jan 6, 2021 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT04584983
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
PHASE2Active, not recruiting
134 participants
Started: Jan 6, 2021 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT04557501
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
PHASE3Active, not recruiting
800 participants
Started: Jan 6, 2021 · Completed: Jan 31, 2029
1 condition10 sponsors19 locations
NCT04672811
Comprehensive and Continuous Status Measurement of Pre- and Post-Deployment Warfighters with Mobile Application
NAEnrolling by invitation
500 participants
Started: Jan 6, 2021 · Completed: Dec 31, 2024
2 conditions2 sponsors2 locations
NCT04619420
A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease
PHASE2Active, not recruiting
523 participants
Started: Jan 6, 2021 · Completed: Dec 30, 2032
3 conditions1 sponsor122 locations
NCT04672005
Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer
PHASE2Active, not recruiting
30 participants
Started: Jan 6, 2021 · Completed: Jun 1, 2025
1 condition1 sponsor7 locations
NCT04369560
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
EARLY_PHASE1Recruiting
42 participants
Started: Jan 6, 2021 · Completed: Dec 30, 2027
1 condition2 sponsors1 location
NCT04335292
Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge
PHASE2Recruiting
200 participants
Started: Jan 6, 2021 · Completed: Jun 1, 2027
1 condition2 sponsors10 locations
NCT04800107
Effect of Highly Bioavailable Curcumin on Subjective Tinnitus
NAActive, not recruiting
110 participants
Started: Jan 6, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT04034550
Cohort of Hospitalized Patients Suspected of Leptospirosis
NAActive, not recruiting
200 participants
Started: Jan 6, 2021 · Completed: Jul 31, 2027
1 condition1 sponsor4 locations
NCT04405401
Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer
PHASE2Recruiting
68 participants
Started: Jan 5, 2021 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT04551430
Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
PHASE2Active, not recruiting
105 participants
Started: Jan 5, 2021 · Completed: Feb 1, 2029
1 condition3 sponsors4 locations
NCT04648267
Factors Affecting Split Thickness Skin Graft Success Rates in Patients Who Underwent a Radial Forearm or Fibula Free Flap
NARecruiting
220 participants
Started: Jan 5, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04481581
Titration of Oxygen Levels During Mechanical Ventilation With Electronic Alerts
NAActive, not recruiting
300 participants
Started: Jan 5, 2021 · Completed: Oct 1, 2025
1 condition2 sponsors1 location
NCT04557618
Auricular VNS Following Subarachnoid Hemorrhage
NARecruiting
50 participants
Started: Jan 5, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04268121
Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas
PHASE2Recruiting
78 participants
Started: Jan 5, 2021 · Completed: Jan 31, 2031
2 conditions2 sponsors14 locations
NCT04728230
Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial
PHASE1/PHASE2Recruiting
63 participants
Started: Jan 5, 2021 · Completed: Dec 31, 2025
4 conditions3 sponsors1 location
NCT04780880
Incidence and Prognostic Factors for Lower Extremities Injuries in Polish Youth Soccer Academy.
N/ARecruiting
120 participants
Started: Jan 5, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04832932
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
N/AActive, not recruiting
2,000 participants
Started: Jan 5, 2021 · Completed: Jan 5, 2025
1 condition2 sponsors5 locations
NCT05034991
The Role of Endometrial Blood Flow in Endometrial Cancer
N/ARecruiting
75 participants
Started: Jan 5, 2021 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05012150
A Pilot Study in Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis
N/ARecruiting
32 participants
Started: Jan 5, 2021 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT04560907
Aquablation vs. Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia in Medium to Large Size Prostates
NARecruiting
120 participants
Started: Jan 5, 2021 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT04774770
HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis
NARecruiting
148 participants
Started: Jan 5, 2021 · Completed: Jun 30, 2024
4 conditions2 sponsors1 location
NCT04521231
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
PHASE1/PHASE2Recruiting
281 participants
Started: Jan 4, 2021 · Completed: May 25, 2029
1 condition2 sponsors44 locations
NCT04648124
VIsual Cerebral ConnecTivity On Functional Magnetic Resonance Imaging in Patients With Hereditary REtinal Dystrophies
N/ARecruiting
200 participants
Started: Jan 4, 2021 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT03941132
Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
PHASE2/PHASE3Active, not recruiting
66 participants
Started: Jan 4, 2021 · Completed: Nov 1, 2026
1 condition3 sponsors2 locations
NCT04766320
Study on TIL for the Treatment of r/r Gynecologic Tumors
PHASE1Recruiting
15 participants
Started: Jan 4, 2021 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT04601116
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
PHASE3Recruiting
3,360 participants
Started: Jan 4, 2021 · Completed: Jan 1, 2035
2 conditions11 sponsors1 location
NCT04764617
Functioning of Elder Muscle; Understanding Recovery
N/AActive, not recruiting
80 participants
Started: Jan 4, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04524533
VR Smoking Cessation During a Dental Hygiene Visit
NAActive, not recruiting
440 participants
Started: Jan 4, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT04838418
Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest
N/AActive, not recruiting
80 participants
Started: Jan 4, 2021 · Completed: Jun 1, 2025
1 condition2 sponsors1 location